Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Drug Resistance

Free Subscription Articles published in J Infect Chemother Retrieve available abstracts of 80 articles: HTML format

Single Articles

August 2022
1. SARWER MI, Khan MT, Khurshid S
   Novel rrs mutations in second-line injectable drug-resistant clinical isolates of Mycobacterium tuberculosis from the Punjab province of Pakistan.
   J Infect Chemother. 2022;28:1119-1124.
   PubMed     Abstract available
   
   
   June 2022
2. KANO R, Noguchi H, Hiruma M
   A deletion mutation in the amino acid sequence of squalene epoxidase in terbinafine-resistant Trichophytonrubrum.
   J Infect Chemother. 2022;28:741-744.
   PubMed     Abstract available
   
   
   May 2022
3. HAYASHI T, Mori N, Yamaguchi T, Komori K, et al
   Invasive pectoral abscess and costal osteomyelitis with bloodstream infection caused by methicillin-resistant Staphylococcus aureus after nasal septoplasty in an immunocompetent adult patient.
   J Infect Chemother. 2022 May 5. pii: S1341-321X(22)00143.
   PubMed     Abstract available
   
   
   
4. IMOTO W, Yamada K, Kuwabara G, Shibata W, et al
   Impact of coronavirus disease 2019 on infectious disease treatment and infection control at a tertiary hospital in Japan.
   J Infect Chemother. 2022;28:616-622.
   PubMed     Abstract available
   
   
   
5. UROOJ M, Ullah R, Ali S, Mohyuddin A, et al
   Elucidation of molecular mechanism for colistin resistance among Gram-negative isolates from tertiary care hospitals.
   J Infect Chemother. 2022;28:602-609.
   PubMed     Abstract available
   
   
   April 2022
6. UEDA T, Nakajima K, Ichiki K, Ishikawa K, et al
   Correction of thrombocytopenia caused by linezolid with scheduled sequential tedizolid use in patients with vertebral osteomyelitis by antibiotic resistant Gram-positive organisms.
   J Infect Chemother. 2022 Apr 24. pii: S1341-321X(22)00112.
   PubMed     Abstract available
   
   
   
7. GOTO A, Komiya K, Yamasue M, Yoshikawa H, et al
   Methicillin-resistant Staphylococcus aureus among elderly patients with community-acquired pneumonia.
   J Infect Chemother. 2022 Apr 15. pii: S1341-321X(22)00127.
   PubMed     Abstract available
   
   
   March 2022
8. FUJIMORI T, Hagiya H, Iio K, Higashionna T, et al
   Vancomycin MIC creep progresses in methicillin-resistant Staphylococcus aureus despite the national antimicrobial stewardship campaign: Single facility data in Japan.
   J Infect Chemother. 2022 Mar 26. pii: S1341-321X(22)00096.
   PubMed     Abstract available
   
   
   
9. TAKAHASHI M, Hagiya H, Tanaka S, Yamamoto K, et al
   Persistent methicillin-resistant Staphylococcus aureus bacteremia in an adult patient with Netherton's syndrome: A case report.
   J Infect Chemother. 2022 Mar 8. pii: S1341-321X(22)00069.
   PubMed     Abstract available
   
   
   February 2022
10. SANO M, Shindo Y, Takahashi K, Okumura J, et al
    Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia.
    J Infect Chemother. 2022 Feb 23. pii: S1341-321X(22)00050.
    PubMed     Abstract available
    
    
    
11. KAWABE Y, Sakurai A, Sasaki T, Hasegawa M, et al
    Native valve infective endocarditis due to sequence type 97 community-associated methicillin-resistant Staphylococcus aureus complicated by meningitis and multiple septic emboli in a young healthy adult.
    J Infect Chemother. 2022 Feb 11. pii: S1341-321X(22)00036.
    PubMed     Abstract available
    
    
    
12. ISHIKAWA K, Matsuo T, Suzuki T, Kawai F, et al
    Penicillin- and third-generation cephalosporin-resistant strains of Streptococcus pneumoniae meningitis: Case report and literature review.
    J Infect Chemother. 2022 Feb 7. pii: S1341-321X(22)00037.
    PubMed     Abstract available
    
    
    
13. ETANI T, Mogami T, Yamaguchi S, Takeda T, et al
    Comparison of drug susceptibility between Escherichia coli detected in stool cultures of patients undergoing transrectal prostate needle biopsy and Escherichia coli in hospital-wide urine antibiograms.
    J Infect Chemother. 2022;28:343-346.
    PubMed     Abstract available
    
    
    
14. WAJIMA T, Sugawara T, Umeda Y, Hagimoto A, et al
    Molecular characterisation of carbapenem- and tigecycline-resistant Klebsiella pneumoniae strains isolated from blood and bile samples.
    J Infect Chemother. 2022;28:187-191.
    PubMed     Abstract available
    
    
    
15. OMORI K, Kitagawa H, Tadera K, Naka Y, et al
    Vertebral osteomyelitis caused by Mycobacteroides abscessus subsp. abscessus resulting in spinal cord injury due to vertebral body fractures.
    J Infect Chemother. 2022;28:290-294.
    PubMed     Abstract available
    
    
    January 2022
16. NAKAI M, Oka K, Watanabe G, Kamei K, et al
    Epidemiology and molecular characterization of fecal carriage of third-generation cephalosporin-resistant enterobacterales among elderly residents in Japan.
    J Infect Chemother. 2022 Jan 14. pii: S1341-321X(22)00001.
    PubMed     Abstract available
    
    
    
17. HASHIMOTO R, Shoji K, Ishiguro A, Miyairi I, et al
    Clinical characteristics of bacteremic urinary tract infection due to third-generation cephalosporin-resistant Escherichia coli in children.
    J Infect Chemother. 2022 Jan 7. pii: S1341-321X(21)00355.
    PubMed     Abstract available
    
    
    
18. TAKAHASHI S, Yasuda M, Wada K, Matsumoto M, et al
    Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report.
    J Infect Chemother. 2022;28:1-5.
    PubMed     Abstract available
    
    
    
19. SATO M, Honda A, Maki H, Toyama K, et al
    Successful treatment of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa after allogeneic hematopoietic stem cell transplantation with colistin and amikacin inhalation therapy.
    J Infect Chemother. 2022;28:91-94.
    PubMed     Abstract available
    
    
    December 2021
20. RESENDIZ-SHARPE A, Merckx R, Verweij PE, Maertens J, et al
    Stable prevalence of triazole-resistance in Aspergillus fumigatus complex clinical isolates in a Belgian tertiary care center from 2016 to 2020.
    J Infect Chemother. 2021;27:1774-1778.
    PubMed     Abstract available
    
    
    
21. NAKAYAMA R, Inoue-Tsuda M, Matsui H, Ito T, et al
    Classification of the metallo beta-lactamase subtype produced by the carbapenem-resistant Pseudomonas aeruginosa isolates in Japan.
    J Infect Chemother. 2021 Dec 1. pii: S1341-321X(21)00112.
    PubMed     Abstract available
    
    
    November 2021
22. MAEDA T, Tsuyuki Y, Goto M, Yoshida H, et al
    Dog/cat-origin quinolone-resistant Streptococcus agalactiae isolates with point mutations in quinolone resistance-determining regions: Relatedness with clonal complex 10.
    J Infect Chemother. 2021 Nov 27. pii: S1341-321X(21)00326.
    PubMed     Abstract available
    
    
    
23. HAMASUNA R, Hanzawa H, Moritomo A, Matsumoto M, et al
    Analysis of fluoroquinolone-resistance using MIC determination and homology modelling of ParC of contemporary Mycoplasma genitalium strains.
    J Infect Chemother. 2021 Nov 23. pii: S1341-321X(21)00322.
    PubMed     Abstract available
    
    
    
24. DOUDOULAKAKIS A, Spiliopoulou I, Giormezis N, Syridou G, et al
    Methicillin-resistant Staphylococcus aureus transmission and hospital-acquired bacteremia in a neonatal intensive care unit in Greece.
    J Infect Chemother. 2021 Nov 13. pii: S1341-321X(21)00196.
    PubMed     Abstract available
    
    
    August 2021
25. KITAGAWA H, Tadera K, Mori M, Kashiyama S, et al
    The effect of pulsed-xenon ultraviolet disinfection on surfaces contaminated with vancomycin-resistant Enterococci in a Japanese hospital.
    J Infect Chemother. 2021 Aug 18. pii: S1341-321X(21)00223.
    PubMed     Abstract available
    
    
    
26. KITAGAWA D, Komatsu M, Nakamura A, Suzuki S, et al
    Nosocomial infections caused by vancomycin-resistant Enterococcus in a Japanese general hospital and molecular genetic analysis.
    J Infect Chemother. 2021 Aug 12. pii: S1341-321X(21)00216.
    PubMed     Abstract available
    
    
    July 2021
27. NAKASE K, Nakanishi-Yamasaki M, Harada K, Koizumi J, et al
    Antimicrobial activity and additive effect of the modified Gingyo-san with antimicrobials against Helicobacter pylori.
    J Infect Chemother. 2021;27:957-961.
    PubMed     Abstract available
    
    
    June 2021
28. KHALIFA HO, Arai T, Majima H, Watanabe A, et al
    Evaluation of Surveyor nuclease for rapid identification of FKS genes mutations in Candida glabrata.
    J Infect Chemother. 2021;27:834-839.
    PubMed     Abstract available
    
    
    May 2021
29. DICKSTEIN Y, Eluk O, Warman S, Aboalheja W, et al
    Wall painting following terminal cleaning with a chlorine solution as part of an intervention to control an outbreak of carbapenem-resistant Acinetobacter baumannii in a neurosurgical intensive care unit in Israel.
    J Infect Chemother. 2021 May 31. pii: S1341-321X(21)00153.
    PubMed     Abstract available
    
    
    
30. SHIRATA M, Ito I, Tanabe N, Konishi S, et al
    Risk factors associated with methicillin-resistant Staphylococcus aureus isolation from serially collected sputum samples of patients hospitalized with pneumonia.
    J Infect Chemother. 2021 May 17. pii: S1341-321X(21)00132.
    PubMed     Abstract available
    
    
    
31. TSUNODA R, Usui M, Tagaki C, Fukuda A, et al
    Genetic characterization of coliform bacterial isolates from environmental water in Thailand.
    J Infect Chemother. 2021;27:722-728.
    PubMed     Abstract available
    
    
    April 2021
32. KIM JO, Yoo IY, Yu JK, Kwon JA, et al
    Predominance and clonal spread of CTX-M-15 in cefotaxime-resistant Klebsiella pneumoniae in Korea and their association with plasmid-mediated quinolone resistance determinants.
    J Infect Chemother. 2021 Apr 1. pii: S1341-321X(21)00088.
    PubMed     Abstract available
    
    
    
33. HAMASUNA R, Aono H, Kawaguchi K, Matsumoto M, et al
    Sensitivity of a transcription-mediated amplification method (Aptima Mycoplasma genitalium assay) to detect M. genitalium in vitro.
    J Infect Chemother. 2021;27:573-577.
    PubMed     Abstract available
    
    
    March 2021
34. WONGNAK K, Pattanachaiwit S, Rattanasirirat W, Limsrivanichakorn S, et al
    First characterization of Tn1546-like structures of vancomycin-resistant Enterococcus faecium Thai isolates.
    J Infect Chemother. 2021 Mar 1. pii: S1341-321X(21)00053.
    PubMed     Abstract available
    
    
    
35. TAKAZONO T, Ito Y, Tashiro M, Nakano Y, et al
    Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis.
    J Infect Chemother. 2021;27:537-539.
    PubMed     Abstract available
    
    
    
36. KAGAMI K, Ishiguro N, Yamada T, Niinuma Y, et al
    Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant gram-negative bacilli.
    J Infect Chemother. 2021;27:473-479.
    PubMed     Abstract available
    
    
    
37. KATO T, Tanaka I, Seyama Y, Sekikawa R, et al
    The effectiveness of prescription support and treatment reporting system on the appropriate usage of oral third-generation cephalosporins.
    J Infect Chemother. 2021;27:419-423.
    PubMed     Abstract available
    
    
    February 2021
38. MITA Y, Inose R, Goto R, Kusama Y, et al
    An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan.
    J Infect Chemother. 2021 Feb 19. pii: S1341-321X(21)00040.
    PubMed     Abstract available
    
    
    
39. NAKAMURA Y, Oishi T, Kaneko K, Kenri T, et al
    Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children.
    J Infect Chemother. 2021;27:271-276.
    PubMed     Abstract available
    
    
    
40. OISHI T, Saito A, Fukuda Y, Kato A, et al
    Analysis of risk factors for multidrug-resistant pathogens and appropriate treatment indications for pneumonia in children with neurologic impairment.
    J Infect Chemother. 2021;27:342-347.
    PubMed     Abstract available
    
    
    
41. ISHIWADA N, Fujimaki K, Matsumoto T, Kiyota H, et al
    Nationwide surveillance of bacterial pathogens isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in
    J Infect Chemother. 2021;27:139-150.
    PubMed     Abstract available
    
    
    January 2021
42. GUNER OZENEN G, Sahbudak Bal Z, Umit Z, Avcu G, et al
    Nosocomial Non-fermentative gram negative bacteria bloodstream infections in children; Risk factors and clinical outcomes of carbapenem resistance.
    J Infect Chemother. 2021 Jan 13. pii: S1341-321X(20)30459.
    PubMed     Abstract available
    
    
    
43. OTA Y, Furuhashi K, Hayashi W, Hirai N, et al
    Daptomycin resistant Enterococcus faecalis has a mutation in liaX, which encodes a surface protein that inhibits the LiaFSR systems and cell membrane remodeling.
    J Infect Chemother. 2021;27:90-93.
    PubMed     Abstract available
    
    
    November 2020
44. CHUKAMNERD A, Pomwised R, Paing Phoo MT, Terbtothakun P, et al
    In vitro synergistic activity of fosfomycin in combination with other antimicrobial agents against carbapenem-resistant Klebsiella pneumoniae isolated from patients in a hospital in Thailand.
    J Infect Chemother. 2020 Nov 18. pii: S1341-321X(20)30411.
    PubMed     Abstract available
    
    
    October 2020
45. OGIHARA S, Inoue O, Yamagami T, Yanagimoto K, et al
    Clinical characteristics and molecular analysis of USA300 and ST 764 methicillin-resistant Staphylococcus aureus isolates from outpatients in Japan by PCR-Based open reading frame typing.
    J Infect Chemother. 2020 Oct 31. pii: S1341-321X(20)30382.
    PubMed     Abstract available
    
    
    September 2020
46. OSHIMA N, Hamada H, Hirose S, Shimoyama K, et al
    Panton-Valentine leukocidin-positive novel sequence type 5959 community-acquired methicillin-resistant Staphylococcus aureus meningitis complicated by cerebral infarction in a 1-month-old infant.
    J Infect Chemother. 2020 Sep 25. pii: S1341-321X(20)30331.
    PubMed     Abstract available
    
    
    August 2020
47. KAWAKAMI N, Namkoong H, Saito F, Ishizaki M, et al
    Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan.
    J Infect Chemother. 2020 Aug 28. pii: S1341-321X(20)30286.
    PubMed     Abstract available
    
    
    
48. KONDO T, Okabayashi K, Sugiura K, Obara H, et al
    Effectiveness of active nasal surveillance culture for Methicillin-resistant Staphylococcus aureus in patients undergoing colorectal surgery.
    J Infect Chemother. 2020 Aug 26. pii: S1341-321X(20)30204.
    PubMed     Abstract available
    
    
    
49. HIYAMA Y, Sato T, Takahashi S, Yamamoto S, et al
    Sitafloxacin has a potent activity for eradication of extended spectrum beta-lactamase-producing fluoroquinolone-resistant Escherichia coli forming intracellular bacterial communities in uroepithelial cells.
    J Infect Chemother. 2020 Aug 4. pii: S1341-321X(20)30222.
    PubMed     Abstract available
    
    
    
50. RUSSO A, Picciarella A, Russo R, Sabetta F, et al
    Clinical features, therapy and outcome of patients hospitalized or not for nursing-home acquired pneumonia.
    J Infect Chemother. 2020;26:807-812.
    PubMed     Abstract available
    
    
    
51. IKEMATSU H, Kawai N, Tani N, Chong Y, et al
    In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018-19 season: Comparison with the 2010-11 to 2017-18 seasons.
    J Infect Chemother. 2020;26:775-779.
    PubMed     Abstract available
    
    
    July 2020
52. PACHANON R, Koide K, Kongsoi S, Nakajima C, et al
    Interaction of the plasmid-encoded quinolone resistance protein QnrB19 with Salmonella Typhimurium DNA gyrase.
    J Infect Chemother. 2020 Jul 12. pii: S1341-321X(20)30188.
    PubMed     Abstract available
    
    
    
53. NISHIKI S, Arima Y, Kanai M, Shimuta K, et al
    Epidemiology, molecular strain types, and macrolide resistance of Treponema pallidum in Japan, 2017-2018.
    J Infect Chemother. 2020 Jul 2. pii: S1341-321X(20)30185.
    PubMed     Abstract available
    
    
    
54. TAKEUCHI N, Ohkusu M, Hishiki H, Fujii K, et al
    First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia.
    J Infect Chemother. 2020;26:749-751.
    PubMed     Abstract available
    
    
    
55. EDA R, Nakamura M, Takayama Y, Maehana S, et al
    Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
    J Infect Chemother. 2020;26:667-671.
    PubMed     Abstract available
    
    
    
56. ADACHI Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, et al
    Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    J Infect Chemother. 2020;26:676-680.
    PubMed     Abstract available
    
    
    
57. YAMADA N, Nakamoto T, Takei H, Shoji T, et al
    Two cases of bacterial meningitis due to meropenem-resistant Streptococcus pneumoniae: A threat of serotype 35B, ST 558 lineage.
    J Infect Chemother. 2020;26:745-748.
    PubMed     Abstract available
    
    
    June 2020
58. SHIMIZU K, Takahashi A, Motooka D, Nakamura S, et al
    Fecal Gram staining of phagocytosed bacteria to differentiate methicillin-resistant Staphylococcus aureus: A case report.
    J Infect Chemother. 2020 Jun 28. pii: S1341-321X(20)30184.
    PubMed     Abstract available
    
    
    
59. MIYASHITA N, Ogata M, Fukuda N, Nomura S, et al
    Detection of Mycoplasma pneumoniae using a highly sensitive rapid diagnostic method with silver amplification technology.
    J Infect Chemother. 2020;26:527-530.
    PubMed     Abstract available
    
    
    
60. WAN D, Jing X, Zhou H, Min X, et al
    Differences between meropenem and imipenem disk to detect carbapenemase in gram-negative bacilli using simplified carbapenem inactivation method.
    J Infect Chemother. 2020;26:636-639.
    PubMed     Abstract available
    
    
    
61. ROSANTIA S, Higa T, Yagi N, Tokunaga T, et al
    Characterization of CTX-M-type-extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from Indonesian undergraduate medical students of a university in Surabaya, Indonesia.
    J Infect Chemother. 2020;26:575-581.
    PubMed     Abstract available
    
    
    
62. MAEDA M, Muraki Y, Anno Y, Sawa A, et al
    Development of the predicted and standardized carbapenem usage metric: Analysis of the Japanese Diagnosis Procedure Combination payment system data.
    J Infect Chemother. 2020;26:633-635.
    PubMed     Abstract available
    
    
    
63. KINOSHITA N, Komura M, Tsuzuki S, Shoji K, et al
    The effect of preauthorization and prospective audit and feedback system on oral antimicrobial prescription for outpatients at a children's hospital in Japan.
    J Infect Chemother. 2020;26:582-587.
    PubMed     Abstract available
    
    
    
64. YAMAGATA A, Ito A, Nakanishi Y, Ishida T, et al
    Prognostic factors in nursing and healthcare-associated pneumonia.
    J Infect Chemother. 2020;26:563-569.
    PubMed     Abstract available
    
    
    May 2020
65. MORIYA M, Tsurukiri J, Nakaminami H, Yamanaka H, et al
    A risk as an infection route: Nasal colonization of methicillin-resistant Staphylococcus aureus USA300 clone among contact sport athletes in Japan.
    J Infect Chemother. 2020 May 29. pii: S1341-321X(20)30156.
    PubMed     Abstract available
    
    
    
66. KIYASU Y, Hitomi S, Funayama Y, Saito K, et al
    Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organisms.
    J Infect Chemother. 2020;26:475-482.
    PubMed     Abstract available
    
    
    
67. TODA H, Tanaka Y, Satoh K, Komatsu M, et al
    Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    J Infect Chemother. 2020;26:451-458.
    PubMed     Abstract available
    
    
    April 2020
68. IKEMATSU H, Kawai N, Tani N, Chong Y, et al
    Duration of fever and PA/I38X-substituted virus emergence in patients treated with baloxavir in the 2018-2019 influenza season.
    J Infect Chemother. 2020;26:400-402.
    PubMed     Abstract available
    
    
    
69. PARK JH, Yamaguchi T, Ouchi Y, Koide K, et al
    WQ-3810 inhibits DNA gyrase activity in ofloxacin-resistant Mycobacterium leprae.
    J Infect Chemother. 2020;26:335-342.
    PubMed     Abstract available
    
    
    
70. YAMADA H, Kiyota H, Ito S, Hosobe T, et al
    The clinical efficacy of garenoxacin for male non-gonococcal urethritis.
    J Infect Chemother. 2020;26:353-357.
    PubMed     Abstract available
    
    
    
71. IGARI H, Yamagishi K, Yamazaki S, Murata S, et al
    A retrospective observational study of antimicrobial treatment for non-tuberculous mycobacteria disease using a nationwide claims database in Japan.
    J Infect Chemother. 2020;26:349-352.
    PubMed     Abstract available
    
    
    March 2020
72. WU D, Wang H, Zhu F, Jiang S, et al
    Characterization of an ST5-SCCmec II-t311 methicillin-resistant Staphylococcus aureus strain with a widespread cfr-positive plasmid.
    J Infect Chemother. 2020 Mar 31. pii: S1341-321X(20)30068.
    PubMed     Abstract available
    
    
    
73. KOSAI K, Yamagishi Y, Hashinaga K, Nakajima K, et al
    Multicenter surveillance of the epidemiology of gram-negative bacteremia in Japan.
    J Infect Chemother. 2020;26:193-198.
    PubMed     Abstract available
    
    
    
74. HARADA S, Ohkushi D, Nakano K, Mitani H, et al
    Fatal invasive pulmonary aspergillosis caused by voriconazole-resistant Aspergillus tubingensis in a patient with solid tumor.
    J Infect Chemother. 2020;26:301-304.
    PubMed     Abstract available
    
    
    
75. MIHARA T, Kimura T, Momiyama K, Kainuma A, et al
    Secondary in-hospital epidemiological investigation after an outbreak of Pseudomonas aeruginosa ST357.
    J Infect Chemother. 2020;26:257-265.
    PubMed     Abstract available
    
    
    
76. TATARA K, Gotoh K, Okumiya K, Teramachi M, et al
    Molecular epidemiology, antimicrobial susceptibility, and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes in Japan.
    J Infect Chemother. 2020;26:280-284.
    PubMed     Abstract available
    
    
    February 2020
77. KOBAYASHI K, Yamamoto S, Takahashi S, Ishikawa K, et al
    The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients.
    J Infect Chemother. 2020 Feb 17. pii: S1341-321X(20)30018.
    PubMed     Abstract available
    
    
    
78. TOYOTOME T, Saito S, Koshizaki Y, Komatsu R, et al
    Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan.
    J Infect Chemother. 2020;26:321-323.
    PubMed     Abstract available
    
    
    January 2020
79. MORI N, Kagawa N, Aoki K, Ishi Y, et al
    Clinical and molecular analyses of bloodstream infections caused by IMP metallo-beta-lactamase-producing Enterobacteriaceae in a tertiary hospital in Japan.
    J Infect Chemother. 2020;26:144-147.
    PubMed     Abstract available
    
    
    December 2019
80. YAMABA Y, Ito Y, Suzuki K, Kikuchi T, et al
    Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
    J Infect Chemother. 2019;25:995-1000.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: